BYNEF yields 3.01% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 8
Combined, BYNEF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BYNEF + JNJ for your $10,000?
Banyan Tree Holdings Limited, an investment holding company, develops, operates, and manages resorts, hotels, spas, and residences in Singapore, South East Asia, Indian Oceania, the Middle East, North East Asia, and internationally. It operates through Hotel Investments, Property Sales, and Fee-Based segments. The company engages in the hotel and restaurant operations; sale of hotel villas or suites to investors under the leaseback scheme; and development and sale of vacation homes in Laguna Phuket, as well as in the land development and sales activities. It is also involved in the management of an asset-backed destination club and private-equity funds; sale of merchandise; provision of architectural and design services; ownership and management of golf courses; and holding of land plots. In addition, the company provides tourist transportation, management consultancy, marketing, business management, investment management and related consulting, and tourism management consultancy services; operation and ancillary services related to the hospitality industry; consultation and management services of the international hotels marketing; purchasing and project services for hotels, resorts, and spas; and designing, planning, and consultancy services for hotels, resorts and spas, as well as owns and manages the intellectual property. Further, it is involved in the holiday club membership and property holding operations; operation, investment, and rental of retail outlets and offices; and development of residential properties. The company manages 29 hotels and resorts, 63 spas, 72 retail galleries, and 3 golf courses. Banyan Tree Holdings Limited was founded in 1984 and is based in Singapore.
Full BYNEF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.